4/A

PRIMARY DOCUMENT

Company: Ultragenyx Pharmaceutical Inc.
Filed: March 28, 2014
Period of Report: February 5, 2014
Accession Number: 0000904454-14-000350

View Document ↗ View on SEC.gov ↗